Stock News & Analysis

The green hydrogen pioneer is advancing toward its profitability goals.

EUFN provides broader geographic diversification across developed Europe with lower volatility, while KBWB concentrates on U.S. banks for more concentrated exposure.

Her funds' daily trade files show the same response to each leg higher in the AI software stock -- while $26.6 million went somewhere much cheaper.

The company is giving its most powerful AI models away while spending as much as $145 billion this year. How does that add up for shareholders?

AMLP offers a 7% dividend yield and lower volatility, while TAN delivers higher growth potential and 41% one-year returns.

Novo Nordisk is playing catch-up in the GLP-1 race.

Small-cap growth fund ISCG delivered stronger returns over the last 12 months, while mega-cap fund MGK had the higher return over the last five years.

The Asia-based company posted its second-quarter results early Tuesday.

Fidelity's broader 104-stock portfolio and lower 0.08% expense ratio deliver superior returns and a 2.2% dividend yield.

While the future of artificial intelligence is still incredibly bright, there is a scenario in which the trade takes a scary turn.

Teekell's $137,370 disposition was executed under a Rule 10b5-1 trading plan adopted several months prior.

Edward Deitzel exercised options at $12.00 and sold shares at $45.78.

Comly exercised fully vested options and sold under a pre-arranged Rule 10b5-1 plan established seven months prior. She retains 883,000 directly held shares.

NuScale Power could become a much larger company if rising power demand translates into a repeatable commercial business.

Is ZETA Global the next big opportunity in marketing tech? Join us as we evaluate its strengths, financials, and potential for growth in this insightful episode.

MIAX's EVP exercised options at $12 and $15.22 and immediately sold at $45.90.

The specialty lender posted a displeasing quarterly earnings report.

Insider exercised stock options at $12 strike and immediately sold at $45.71 per share under pre-scheduled trading plan adopted in December 2025.

Thomas Gallagher exercised vested options under a pre-established trading plan, retaining 1.7 million shares and 235,000 derivative securities through an investment LLC.

The beaten-down adtech took another hit, this time from an analyst's recommendation downgrade.